Mitragyna rotundifolia (Rubiaceae) Round-leaf Mitragyna, Bhumikadamba

Mitragyna rotundifolia is a deciduous tree native to the forests of South and Southeast Asia, including India, Myanmar, Thailand, Laos, and southern China. It is a lesser-known member of the Mitragyna genus, which is more famous for its relative, M. speciosa (kratom). In traditional medicine, this plant has been used to treat nervous conditions and lung diseases, while modern research is discovering a complex profile of bioactive compounds with significant antioxidant, cytotoxic, and neurological activities.

1. Taxonomic Insights

Species: Mitragyna rotundifolia (Roxb.) Kuntze

Family: Rubiaceae

The Rubiaceae family, commonly known as the coffee, madder, or bedstraw family, is one of the largest families of flowering plants. It includes economically significant plants like coffee (Coffea), quinine (Cinchona), and numerous ornamentals (gardenias, ixoras). The genus Mitragyna is named from the Greek mitra (headband) and gyne (woman), referring to the mitre-like shape of the stigma. This genus contains about 10 species native to tropical Africa and Asia.

Taxonomic Note: The species was first described as Nauclea rotundifolia by William Roxburgh, before being reclassified under the genus Mitragyna by Carl Ernst Otto Kuntze in 1891. It is a tree that can grow up to 30 metres tall, with distinctive, large, round to broadly oval leaves that are pubescent (hairy) on the underside. The small, pale yellow flowers are borne in dense, round heads, and the fruit is a cluster of small, glabrous capsules. The name "rotundifolia" translates to "round-leaved," a key identifying feature.

Related Herbs from the Same Family:

· Mitragyna speciosa (Kratom): The most famous member of the genus, known for its psychoactive alkaloids, mitragynine and 7-hydroxymitragynine, which have both stimulant and opioid-like effects.

· Coffea arabica (Coffee): A globally important crop, known for its stimulating effects due to caffeine. It shares the family's rich alkaloid chemistry.

· Cinchona officinalis (Quinine Bark): A tree native to South America, historically crucial for treating malaria due to its quinine content.

· Rubia cordifolia (Indian Madder): A climbing plant whose roots are a source of red dye and are used in traditional medicine for their anti-inflammatory and astringent properties.

2. Common Names

Scientific Name: Mitragyna rotundifolia | English: Round-leaf Mitragyna | Sanskrit: Bhumikadamba | Hindi: Binga | Assamese: Timi | Mizo: Thinglung | Thai: Kra thum noen (กระทุ่มเนิน), Kaen lueang (แก่นเหลือง) | Lao: Tome nam (ໂທມ ນ້ຳ) | Chinese: Mao zhu mu (帽柱木), Mao rui mu (帽蕊木) | Malayalam: Binga | Burmese: Let-khat

3. Medicinal Uses

Primary Actions: Antioxidant, Cytotoxic (against certain cancer cell lines), Neurological (Opioid receptor activity)

Secondary Actions: Analgesic, Sedative, Antimicrobial, Hepatoprotective

Medicinal Parts:

The leaves, bark, and wood are the primary parts used medicinally.

· Leaves: In traditional medicine, the leaves are used to treat nervous conditions. Modern research has identified them as a rich source of phenolic compounds and flavonoids, which are responsible for potent antioxidant activity. The leaves have also been found to contain the alkaloid rhynchophylline, which interacts with opioid receptors.

· Bark: The stem bark is a source of triterpenoids, such as rotundic acid, which has been studied for its cytotoxic activity against breast and colon cancer cell lines.

· Wood: The wood is traditionally used for treating lung disease.

4. Phytochemicals Specific to the Plant and Their Action

The phytochemistry of Mitragyna rotundifolia is diverse, with significant variations in compound classes found in the leaves and bark.

· Phenolic Compounds and Flavonoids (Leaves): The leaves are a rich source of polyphenols and flavonoids, which are the primary agents behind its antioxidant activity. Key compounds isolated include 3,4-dihydroxybenzoic acid (protocatechuic acid), caffeic acid, kaempferol, 4'-O-methyl-gallocatechin, catechin, and epi-catechin. These compounds act as powerful free radical scavengers. More polar extracts (like those from ethyl acetate and n-butanol) have shown higher activity than non-polar extracts.

· Oxindole Alkaloids (Leaves): This is a key area of modern research. The leaf extract of M. rotundifolia contains rhynchophylline as a major component (34.75% of the ethanol extract). Trace amounts of mitragynine, 7-hydroxymitragynine, and mitraphylline have also been found.

· Triterpenoids (Bark): Rotundic acid, a triterpenoid, has been isolated from the stem bark and demonstrates significant cytotoxic activity. Research indicates it induces apoptosis in breast cancer cells (MCF-7) through the p53 pathway, potentially making it a candidate for combined gene therapy approaches in cancer treatment.

5. Traditional and Ethnobotanical Uses Covering the Medicinal Uses

Nervous Conditions and Sleep

Formulation: Leaf decoction.

Preparation and Use: In Laos, the leaves are traditionally used to treat "nervous conditions". The presence of rhynchophylline, which binds to the µ-opioid receptor, and its previously published sleep-inducing activity, provide a chemical basis for this traditional use. Studies show M. rotundifolia extract has a low relative µ-opioid receptor gene expression (16.89 at 0.189 mg/ml), indicating a mild interaction that could contribute to a calming or sedative effect rather than a strong opioid effect.

Reasoning: The interaction of rhynchophylline with the µ-opioid receptor is known to produce effects like sedation and analgesia. When combined with other plants containing oleamide (which relieves stress and induces deep sleep), formulations of M. rotundifolia show a significantly enhanced binding affinity to the µ-opioid receptor, supporting its traditional use for neurological issues.

Lung Disease

Formulation: Wood decoction.

Preparation and Use: In some traditional practices, the wood is used to treat lung diseases.

Reasoning: While the specific compounds and mechanisms for this use are not fully elucidated, the plant's potent antioxidant and anti-inflammatory properties likely play a role in supporting respiratory health and reducing inflammation associated with lung conditions.

Cancer (Cytotoxic Activity)

Formulation: Bark extract (under research).

Preparation and Use: This is a modern, research-based application, not a traditional one. The active compound, rotundic acid, has shown promise in laboratory studies for its ability to induce cell death in cancer cells.

Reasoning: Rotundic acid induces apoptosis (programmed cell death) in MCF-7 breast cancer cells via the p53 pathway. It has also shown activity against colon cancer cells. This highlights the potential of this compound for development as a novel drug, particularly when combined with therapies targeting caspase-3 deficiency.

6. Healing Recipes, Decoctions, and Preparations

Traditional Leaf Decoction for Nervous Tension

Purpose: To promote a sense of calm and relieve nervous tension.

Preparation and Use:

1. Take a handful of dried Mitragyna rotundifolia leaves.

2. Simmer them in 500 ml of water for 15 minutes.

3. Strain the decoction and drink it warm in the evening.

4. This should be used as a supportive measure and not as a substitute for professional care.

Note on Combination Use: Research suggests that a combination of M. rotundifolia and Ipomoea aquatica (water spinach) extract shows high relative µ-opioid receptor gene expression, potentially offering a more potent effect for stress relief and sleep. This synergy is the subject of a registered patent and highlights the potential of combining the sleep-inducing properties of M. rotundifolia with the stress-relieving properties of oleamide from I. aquatica.

Antioxidant Leaf Tea

Purpose: To support general health and fight oxidative stress.

Preparation and Use:

1. Infuse a few dried leaves or a handful of fresh leaves in a cup of hot water.

2. Allow it to steep for 10 minutes.

3. Strain and drink.

Culinary Uses of Mitragyna rotundifolia

Unlike its relative kratom, which is often chewed, M. rotundifolia is not a common culinary plant. There are no widely documented culinary uses for its leaves or fruits. Its primary use remains in traditional medicine.

Foraging and Preparation Notes

Harvesting: Leaves are best harvested during the growing season (flowering from June to November). Bark is typically harvested from mature trees. Sustainable harvesting practices are crucial as the tree is part of a genus with significant pharmacological interest.

Sustainability: While not currently listed as threatened, habitat loss and over-harvesting for research and potential future commercialisation could pose a risk to wild populations.

7. In-Depth Phytochemical Profile and Clinical Significance of Mitragyna rotundifolia

Introduction

Mitragyna rotundifolia is an emerging plant in the field of pharmacognosy, offering a unique bridge between traditional folk medicine and cutting-edge cancer research. Its therapeutic identity is defined by two distinct phytochemical profiles: a rich store of antioxidant flavonoids and phenolics in its leaves, and powerful cytotoxic triterpenoids in its bark. The recent discovery of opioid receptor-binding alkaloids in the leaves adds another layer of complexity, positioning M. rotundifolia as a plant with significant potential in neurology, oncology, and infectious disease research.

1. Flavonoids and Phenolics: The Antioxidant Arm

Key Compounds: Kaempferol, Catechin, Epicatechin, Caffeic acid, Protocatechuic acid.

Quantitative Profile: The leaf extracts, particularly those from ethyl acetate and n-butanol, are rich in these compounds. In the ABTS assay, the 1/IC50 values were highly correlated with the total flavonoid content (R² = 0.955), underscoring the role of flavonoids in the antioxidant effect. The total phenolic content was also significant, with leaf extracts showing higher content than bark extracts for the same solvent.

Actions and Clinical Relevance:

· Antioxidant: The compounds act as powerful chain-breaking antioxidants. They scavenge free radicals, reducing oxidative stress, which is a key factor in ageing and chronic diseases like cardiovascular disease and cancer.

· Anti-inflammatory: While not explicitly quantified in the research, the presence of phenolic acids and flavonoids like caffeic acid and quercetin derivatives are well-known for their anti-inflammatory properties.

2. Oxindole Alkaloids: The Neurological and Analgesic Arm

Key Compounds: Rhynchophylline (major), Mitragynine (trace), Mitraphylline (trace), 7-Hydroxymitragynine (trace).

Pharmacological Profile: Rhynchophylline was found to be a major component of the ethanolic leaf extract, comprising 34.75% of its composition. The extract demonstrated a low but measurable affinity for the µ-opioid receptor (MOR) in gene expression assays, showing a relative expression of 16.89 at 0.189 mg/ml.

Actions and Clinical Relevance:

· CNS Depressant and Analgesic: Rhynchophylline is a known compound with sedative and pain-relieving properties. It binds to opioid receptors, particularly the µ-opioid receptor (MOR), which is the primary target for many opioid analgesics.

· Safety Profile: Crucially, the extracts of M. rotundifolia showed no cytotoxicity and no significant genotoxicity in human peripheral blood mononuclear cells (PBMCs), suggesting a favourable safety profile compared to some other Mitragyna species like M. hirsuta, which showed DNA damage.

3. Triterpenoids: The Anticancer Arm

Key Compounds: Rotundic acid.

Pharmacological Profile: Rotundic acid is a triterpenoid isolated from the stem bark. Its primary action is cytotoxic, particularly against certain cancer cell lines.

Actions and Clinical Relevance:

· Cytotoxic (Breast Cancer): Rotundic acid induces cell death via the p53 pathway in MCF-7 breast cancer cells. Its potency, with an IC50 > 50 µmol/L, is under investigation for its potential in cancer therapy.

· Cytotoxic (Colon Cancer): The compound has also shown activity against HT-29 colon cancer cells.

An Integrated View of Healing in Mitragyna rotundifolia

· For Neurological Health and Pain: This plant provides a natural compound (rhynchophylline) with mild opioid-receptor activity and sedative properties. Its traditional use for "nervous conditions" and lung disease is now being scientifically supported, offering a potential path to safer analgesics and sleep aids.

· For Cancer Therapy: The isolation of rotundic acid places M. rotundifolia in the spotlight for oncology research. Its mechanism of inducing apoptosis in breast cancer cells is a direct validation of the ethnobotanical practice of using the bark.

· For General Health: The high antioxidant content of the leaves makes it a valuable source of natural compounds that can help protect the body from oxidative damage, linking it to the broader family of health-promoting plants.

Toxicological Profile and Quality Control

Safety Profile: Mitragyna rotundifolia is showing significant potential as a safe medicinal plant. Genotoxicity and cytotoxicity assays on human cells have demonstrated no significant DNA damage or cell death for ethanol and hexane leaf extracts, marking it as safer than some other species in the genus, such as M. hirsuta. However, comprehensive data for long-term use and concentrated extracts are still emerging.

Quality Control Parameters: The identification of rhynchophylline as a major alkaloid marker (34.75%) and the presence of specific flavonoids like kaempferol and catechin provide excellent targets for quality control and standardisation of extracts for future research and products.

Conclusion: Mitragyna rotundifolia is a plant of enormous, yet largely untapped, potential. It seamlessly integrates traditional uses for nervous and lung conditions with modern pharmacological validation as a potent source of antioxidants and a promising anticancer agent. Its significantly better safety profile compared to other Mitragyna species makes it an even more compelling subject for research. As studies continue, this plant stands to bridge the gap between ancient wisdom and modern medicine, potentially offering new, safer therapies for pain, sleep, and cancer treatment.

Disclaimer:

Mitragyna rotundifolia shows a favourable safety profile in preliminary studies, but comprehensive data, particularly for concentrated extracts and long-term use, are still emerging. Its alkaloid content interacts with opioid receptors, and it should be used with caution and only under the guidance of a qualified healthcare professional. This information is for educational use only and is not a substitute for professional medical advice.

8. Reference Books, Books for In-depth Study

· "Flora of China" (Rubiaceae Volume) - for botanical description and distribution.

· "Medicinal Plants of Laos" (Field Museum) - for ethnobotanical and traditional use documentation.

· "Journal of Ethnopharmacology" - for reviews on the ethnomedicinal uses and pharmacological studies of the Mitragyna genus.

· "Scientific Reports" (2025) - for the discovery of rhynchophylline and opioid gene expression analysis.

· "Medicinal Chemistry Research" (2010) - for the antioxidant phenolic compounds and flavonoids study.

· "PhytoCAT" (IGIB) - for rotundic acid, its cytotoxic activity, and target pathways.

9. Further Study: Plants That Might Interest You Due to Similar Medicinal Properties

1. Mitragyna speciosa (Kratom)

· Species: Mitragyna speciosa | Family: Rubiaceae

· Similarities: The most famous relative, with a rich profile of opioid alkaloids. It is used traditionally for pain, energy, and as an opium substitute. Its primary compounds, mitragynine and 7-hydroxymitragynine, are well-studied for their analgesic and stimulant properties.

2. Uncaria rhynchophylla (Cat's Claw)

· Species: Uncaria rhynchophylla | Family: Rubiaceae

· Similarities: A woody vine from the same family, whose primary active compound is rhynchophylline (also found in M. rotundifolia). It is well-known in traditional Chinese medicine for treating hypertension, epilepsy, and neurological conditions due to its sedative and neuroprotective properties.

3. Camptotheca acuminata (Happy Tree)

· Species: Camptotheca acuminata | Family: Nyssaceae

· Similarities: A tree native to China, known for its potent anticancer compound, camptothecin. Like M. rotundifolia, which contains rotundic acid, it is a prime example of a plant yielding a powerful cytotoxic agent with significant implications for cancer therapy.

4. Physalis peruviana (Goldenberry)

· Species: Physalis peruviana | Family: Solanaceae

· Similarities: A plant with potent antioxidant properties due to its high phenolic and flavonoid content. It shares the role of M. rotundifolia as a source of natural antioxidants used to combat oxidative stress and inflammation.

-x-xEnd-x-x